Replies to post #520036 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Very key here: The fact that the design was approved and endpoints (ECAs) and trial design (same SAP) are the same as the adult Phase 3 is a glaring admission that everything is on track in the UK.

Approving ECAs in a single arm P2 trial is far different that using them in a randomized P3.

And it is not the same SAP..

[Fireman02360]

Yes. Notice how this subject doesnt get much mention anymore. Funny how that works.

One bowling pin at a time. The "strike" comes in November. Just watch.

-Fireman

[OilPatch]

Do you think UK approval and rollout translates to a better chance of a FDA approval?